LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors
- PMID: 7588309
- DOI: 10.1210/endo.136.12.7588309
LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors
Abstract
Mineralocorticoid receptors (MRs) are nonselective in vitro, binding corticosterone, cortisol, and aldosterone with similar affinity. In the distal nephron in vivo, MRs are selectively activated by aldosterone despite much higher glucocorticoid levels. This has been suggested to reflect the action of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD), which catalyzes rapid inactivation of corticosterone to 11-dehydrocorticosterone (cortisol to cortisone). However, cellular models of this effect have not been reported, and a recent study suggested that properties intrinsic to MR contribute to aldosterone selectivity. We have screened clonal mammalian cell lines for 11 beta-HSD activity. Pig kidney epithelial LLC-PK1 cells expressed by far the greatest 11 beta-HSD activity. In cell homogenates, this was NAD-dependent, with Km for corticosterone of 34.4 nM and cortisol of 89.7 nM. Intact LLC-PK1 cells showed similar apparent Km for corticosterone (13.9 nM) and cortisol (79.4 nM); only 11 beta-dehydrogenation was detected. These biochemical data indicate the expression of the type 2 isoform, 11 beta-HSD2. Using primers to conserved regions of 11 beta-HSD2, a reverse transcriptase-polymerase chain reaction product was obtained from LLC-PK1 cell RNA. Sequence analysis revealed close homology to previously cloned 11 beta-HSD2 cDNAs from several species. LLC-PK1 cell 11 beta-HSD activity was inhibited by carbenoxolone (IC50 approximately 10(-8) M) and high concentrations of estradiol or progesterone (10(-7) and 10(-6) M), but was induced at lower estradiol concentrations (10(-8) and 10(-9) M). To examine whether the 11 beta-HSD2 activity in LLC-PK1 cells regulates corticosterone access to MR, cells were transfected with the corticosteroid-inducible mouse mammary tumor virus long terminal repeat-luciferase reporter construct. Cell transfection by a lipofection method did not alter 11 beta-HSD activity in LLC-PK1 cells. LLC-PK1 cells expressed low levels of MR (13.9 fmol/mg protein, dissociation constant (Kd) 0.3 x 10(-9) M for aldosterone) and glucocorticoid receptors (GR; 18.5 fmol/mg protein, Kd 0.3 x 10(-9) M for dexamethasone). Transfection with mouse mammary tumor virus long terminal repeat-luciferase reporter construct alone suggested that the endogenous levels of MR and GR were insufficient to affect transcription. However, cotransfection of LLC-PK1 cells with pRShMR, an MR expression plasmid, allowed at least 50-fold induction of luciferase with 10(-8) M aldosterone; the ED50 0.3 x 10(-9) M closely reflects the in vitro affinity of MR for aldosterone. Corticosterone only weakly induced luciferase (maximum of 6-fold induction).(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Characterization of 11beta-hydroxysteroid dehydrogenase activities in the renal cell line LLC-PK1: evidence for a third isoform?Endocrine. 1999 Dec;11(3):301-7. Endocrine. 1999. PMID: 10786827
-
Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action.Endocrinology. 1993 Jun;132(6):2287-92. doi: 10.1210/endo.132.6.8504732. Endocrinology. 1993. PMID: 8504732
-
Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.J Clin Endocrinol Metab. 1994 Aug;79(2):480-4. doi: 10.1210/jcem.79.2.8045966. J Clin Endocrinol Metab. 1994. PMID: 8045966
-
The role of 11beta-hydroxysteroid dehydrogenase in steroid hormone specificity.J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):311-6. doi: 10.1016/s0960-0760(98)00009-0. J Steroid Biochem Mol Biol. 1998. PMID: 9699885 Review.
-
11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.Endocr Rev. 1997 Feb;18(1):135-56. doi: 10.1210/edrv.18.1.0288. Endocr Rev. 1997. PMID: 9034789 Review.
Cited by
-
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.Physiol Rev. 2013 Jul;93(3):1139-206. doi: 10.1152/physrev.00020.2012. Physiol Rev. 2013. PMID: 23899562 Free PMC article. Review.
-
Alternative splicing determines sensitivity of murine calcium-activated potassium channels to glucocorticoids.J Physiol. 2001 Nov 15;537(Pt 1):57-68. doi: 10.1111/j.1469-7793.2001.0057k.x. J Physiol. 2001. PMID: 11711561 Free PMC article.
-
Dex-ras1 and serum- and glucocorticoid-inducible protein kinase 1: regulation of expression by dexamethasone in HEK293 cells.Neurochem Res. 2008 Apr;33(4):609-13. doi: 10.1007/s11064-007-9516-5. Epub 2007 Nov 6. Neurochem Res. 2008. PMID: 17985234
-
Effect of angiotensin II on rat renal cortical 11beta-hydroxysteroid dehydrogenase.Endocrine. 2000 Dec;13(3):393-9. doi: 10.1385/endo:13:3:393. Endocrine. 2000. PMID: 11216653
-
Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivo.Antioxid Redox Signal. 2014 Nov 20;21(15):2126-42. doi: 10.1089/ars.2013.5565. Epub 2014 Mar 21. Antioxid Redox Signal. 2014. PMID: 24512358 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources